BENUSSI, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 9.453
AS - Asia 5.041
EU - Europa 3.654
SA - Sud America 963
Continente sconosciuto - Info sul continente non disponibili 264
AF - Africa 137
OC - Oceania 17
Totale 19.529
Nazione #
US - Stati Uniti d'America 9.084
SG - Singapore 1.863
CN - Cina 1.382
IT - Italia 1.151
BR - Brasile 790
HK - Hong Kong 572
DE - Germania 528
UA - Ucraina 372
VN - Vietnam 335
GB - Regno Unito 326
FI - Finlandia 306
BD - Bangladesh 283
FR - Francia 247
RU - Federazione Russa 205
TR - Turchia 165
CA - Canada 160
IE - Irlanda 140
IN - India 123
MX - Messico 74
NL - Olanda 72
AR - Argentina 62
ZA - Sudafrica 50
PL - Polonia 47
CZ - Repubblica Ceca 44
JP - Giappone 43
BE - Belgio 40
IQ - Iraq 37
ES - Italia 36
PK - Pakistan 32
SE - Svezia 32
AT - Austria 28
ID - Indonesia 27
SA - Arabia Saudita 26
EC - Ecuador 25
CR - Costa Rica 24
HN - Honduras 22
UZ - Uzbekistan 21
CO - Colombia 20
VE - Venezuela 20
JM - Giamaica 18
MA - Marocco 17
IL - Israele 16
AU - Australia 15
EE - Estonia 15
PY - Paraguay 15
TW - Taiwan 14
EG - Egitto 12
NI - Nicaragua 12
SV - El Salvador 12
CL - Cile 11
LT - Lituania 11
NP - Nepal 11
JO - Giordania 10
UY - Uruguay 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
GT - Guatemala 8
KE - Kenya 8
PH - Filippine 8
TN - Tunisia 8
DO - Repubblica Dominicana 7
LB - Libano 7
DK - Danimarca 6
IR - Iran 6
KZ - Kazakistan 6
PR - Porto Rico 6
RO - Romania 6
SC - Seychelles 6
TT - Trinidad e Tobago 6
BY - Bielorussia 5
CH - Svizzera 5
DZ - Algeria 5
ET - Etiopia 5
GP - Guadalupe 5
KG - Kirghizistan 5
NG - Nigeria 5
PE - Perù 5
BG - Bulgaria 4
BH - Bahrain 4
BO - Bolivia 4
CG - Congo 4
CI - Costa d'Avorio 4
EU - Europa 4
KR - Corea 4
MD - Moldavia 4
MY - Malesia 4
PA - Panama 4
RS - Serbia 4
SN - Senegal 4
AL - Albania 3
CW - ???statistics.table.value.countryCode.CW??? 3
GD - Grenada 3
GE - Georgia 3
OM - Oman 3
PT - Portogallo 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
BZ - Belize 2
GA - Gabon 2
Totale 19.237
Città #
Singapore 996
Ashburn 859
Fairfield 699
San Jose 628
Hong Kong 568
Woodbridge 385
Council Bluffs 376
New York 372
Beijing 328
Chandler 318
The Dalles 306
Jacksonville 297
Houston 258
Seattle 256
Wilmington 255
Cambridge 250
Helsinki 231
Ann Arbor 227
Los Angeles 217
Princeton 201
Milan 166
Munich 155
Dublin 138
Lauterbourg 136
Dallas 128
Istanbul 128
Ho Chi Minh City 124
Brescia 106
São Paulo 100
Santa Clara 95
Nanjing 82
Dearborn 77
San Francisco 70
Shanghai 70
Buffalo 69
Redondo Beach 69
Chicago 68
Des Moines 68
Hanoi 67
North Bergen 62
Rome 62
Moscow 61
Turku 60
Columbus 58
London 54
Phoenix 52
Montreal 46
Jinan 40
Boardman 39
Brussels 39
Warsaw 39
Denver 38
San Diego 38
Nanchang 36
Nuremberg 36
Orem 36
Atlanta 35
Toronto 34
Hebei 33
Tokyo 33
Johannesburg 32
Mexico City 32
Changsha 31
Olomouc 30
Shenyang 29
Chennai 28
Frankfurt am Main 28
Brooklyn 27
Charlotte 26
Carrboro 24
Naples 24
Turin 24
Manchester 23
Rio de Janeiro 23
Boston 22
Lancaster 22
Amsterdam 20
Belo Horizonte 20
Guangzhou 20
Mumbai 20
Philadelphia 19
Dhaka 18
Stockholm 18
Bologna 17
Hangzhou 17
Tashkent 17
Vienna 17
Poplar 16
Tianjin 16
Augusta 15
Brasília 15
Norwalk 15
San José 15
San Mateo 15
Washington 15
Florence 14
Kunming 14
Ningbo 14
Palermo 14
Da Nang 13
Totale 11.693
Nome #
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 381
COVID-19 impact on consecutive neurological patients admitted to the emergency department 273
Validation and convergent validity of the Boston cognitive assessment (BOCA) in an Italian population: a comparative study with the Montreal cognitive assessment (MoCA) in Alzheimer's disease spectrum 258
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 250
Discrimination of atypical parkinsonisms with transcranial magnetic stimulation 244
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy 231
Mendelian forms of disease and age at onset affect survival in frontotemporal dementia 217
Cortico-spinal tDCS in ALS: A randomized, double-blind, sham-controlled trial 217
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy 197
Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure 196
The impact of transcranial magnetic stimulation on diagnostic confidence in patients with Alzheimer disease 195
Autoimmunity and frontotemporal dementia 191
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 190
Clinical and biomarker changes in presymptomatic genetic frontotemporal dementia 182
Metodo di generazione di un indice diagnostico per malattia di alzheimer, apparato elettronico di implementazione del metodo e sistema 177
Enhancing theory of mind in behavioural variant frontotemporal dementia with transcranial direct current stimulation 176
Sensitivity and specificity of transcranial magnetic stimulation for differential diagnosis of Alzheimer’s disease and frontotemporal dementia 173
Diagnosing Progressive Supranuclear Palsy: Role of Biological and Neuroimaging Markers 172
Association of APOE genotype with blood-brain barrier permeability in neurodegenerative disorders 168
New insights into the genetic etiology of Alzheimer’s disease and related dementias 167
Cerebellar transcranial direct current stimulation in patients with ataxia: A double-blind, randomized, sham-controlled study. 165
Natural history and predictors of survival in progressive supranuclear palsy. 161
Biological, Neuroimaging, and Neurophysiological Markers in Frontotemporal Dementia: Three Faces of the Same Coin. 160
Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study 159
Serum neurofilament light in professional soccer players: goal on safety 158
Multimodal Brain Analysis of Functional Neurological Disorders: A Functional Stroke Mimic Case Series. 158
Progression of behavioural disturbances in frontotemporal dementia: a longitudinal observational study 158
Author response: Cerebello-spinal tDCS in ataxia: A randomized, double-blind, sham-controlled, crossover trial 157
Neuroanatomical Correlates of Transcranial Magnetic Stimulation in Presymptomatic Granulin Mutation Carriers. 156
Phenotypic heterogeneity of Niemann-Pick disease type C in monozygotic twins. 153
Detection of TDP-43 seeding activity in the olfactory mucosa from patients with frontotemporal dementia 151
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study 150
Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA 150
Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia. 149
Response to comments on natural history and predictors of survival in progressive supranuclear palsy 149
The impact of TMS on the differential diagnosis and progression of dementia 148
Italian Frontotemporal Dementia Network (FTD Group-SINDEM): sharing clinical and diagnostic procedures in Frontotemporal Dementia in Italy. 144
Method of generation of a diagnostic index for Alzheimer disease, electronic apparatus for implementation of the method and system 144
Modulating risky decision-making in Parkinson's disease by transcranial direct current stimulation. 144
Cerebrospinal fluid tau levels predict prognosis in non-inherited frontotemporal dementia. 143
Cerebello-spinal tDCS in ataxia: A randomized, double-blind, sham-controlled, crossover trial 143
Clinical, genetic, and neuroimaging features of Early Onset Alzheimer Disease: the challenges of diagnosis and treatment. 141
Preliminary Results on Long-Term Potentiation-Like Cortical Plasticity and Cholinergic Dysfunction After Miglustat Treatment in Niemann-Pick Disease Type C. 140
Embedded platform-based system for early detection of Alzheimer disease through transcranial magnetic stimulation 140
Cerebello-spinal stimulation in neurodegenerative ataxia: A randomized, double-blind, sham-controlled, crossover trial 140
Long term clinical and neurophysiological effects of cerebellar transcranial direct current stimulation in patients with neurodegenerative ataxia. 139
Transcranial magnetic stimulation and amyloid markers in mild cognitive impairment: Impact on diagnostic confidence and diagnostic accuracy 139
Clinical and neurophysiological characteristics of heterozygous NPC1 carriers 138
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia 138
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia 137
Classification accuracy of TMS for the diagnosis of mild cognitive impairment 137
Toward a Glutamate Hypothesis of Frontotemporal Dementia 136
TMS for staging and predicting functional decline in frontotemporal dementia 136
Recent neuroimaging, neurophysiological, and neuropathological advances for the understanding of NPC 135
An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation Carriers 135
Association of Choroid Plexus Volume With Serum Biomarkers, Clinical Features, and Disease Severity in Patients With Frontotemporal Lobar Degeneration Spectrum 134
Facial feedback and autonomic responsiveness reflect impaired emotional processing in Parkinson's Disease. 134
Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia 134
Hierarchical spectral clustering reveals brain size and shape changes in asymptomatic carriers of C9orf72 133
Classification Accuracy of Transcranial Magnetic Stimulation for the Diagnosis of Neurodegenerative Dementias 133
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses 133
Treatment with docosahexaenoic acid in Spinocerebellar Ataxia 38 132
Cortical Inhibitory Imbalance in Functional Paralysis 131
Cognitive composites for genetic frontotemporal dementia: GENFI-Cog 131
Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores 130
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI 128
Modulation of long-term potentiation-like cortical plasticity in the healthy brain with low frequency-pulsed electromagnetic fields 127
Altered inhibitory interaction among inferior frontal and motor cortex in l-dopa-induced dyskinesias 127
CSF p-Tau181/Tau ratio to distinguish FTLD-TDP from FTLD-Tau 127
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study 127
Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia. 126
Impaired long-term potentiation-like cortical plasticity in presymptomatic genetic frontotemporal dementia. 126
Mild cognitive impairment in Parkinson's disease is improved by transcranial direct current stimulation combined with physical therapy. 126
Variability and predictors of response to continuous theta burst stimulation: A TMS-EEG study 126
Exposure to gamma tACS in Alzheimer's disease: A randomized, double-blind, sham-controlled, crossover, pilot study 124
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study 123
Differences and similarities between familial and sporadic frontotemporal dementia: An Italian single-center cohort study 122
Clinical and radiological features of posterior cortical atrophy (PCA) in a GRN mutation carrier: a case report 122
Alterations of frontal-temporal gray matter volume associate with clinical measures of older adults with COVID-19 122
Diagnostic Accuracy of the Five-Word Test for Mild Cognitive Impairment Due to Alzheimer’s Disease 121
Expanding the role of education in frontotemporal dementia: a functional dynamic connectivity (the chronnectome) study 121
Transcranial stimulation in frontotemporal dementia: A randomized, double-blind, sham-controlled trial 121
Transcranial Magnetic Stimulation in Alzheimer's Disease and Cortical Dementias 119
Imaging features and ultraearly hematoma growth in intracerebral hemorrhage associated with COVID-19 118
CSF p-Tau181/Tau ratio as biomarker for TDP pathology in Frontotemporal Dementia 117
Differences Between Plasma and Cerebrospinal Fluid p-tau181 and p-tau231 in Early Alzheimer's Disease 115
Motor and cognitive outcomes of cerebello-spinal stimulation in neurodegenerative ataxia 115
Comparing Cerebellar tDCS and Cerebellar tACS in Neurodegenerative Ataxias Using Wearable Sensors: A Randomized, Double-Blind, Sham-Controlled, Triple-Crossover Trial 114
Sex Differences in the Severity and Progression of Neuropsychiatric Symptoms Across Different Dementia Types 114
Clinical outcome of neurological patients with COVID-19: the impact of healthcare organization improvement between waves 113
Citicoline Treatment in Acute Ischemic Stroke: A Randomized, Single-Blind TMS Study 112
Neurophysiological Correlates of Positive and Negative Symptoms in Frontotemporal Dementia 112
Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia 111
Effects of COVID-19 outbreak on stroke admissions in Brescia, Lombardy, Italy 111
Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia 111
Anti-GluA3 autoantibodies define a new sub-population of frontotemporal lobar degeneration patients with distinct neuropathological features 109
Structural brain splitting is a hallmark of Granulin-related frontotemporal dementia 108
Impairment of episodic memory in genetic frontotemporal dementia: A genfi study 108
Vortioxetine Treatment for Depression in Patients with Prodromal vs Mild Alzheimer’s Disease: A Six-Month, Open-Label, Observational Study 107
Dissemination in time and space in presymptomatic granulin mutation carriers: a GENFI spatial chronnectome study 107
Totale 14.848
Categoria #
all - tutte 102.037
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.037


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022668 0 0 0 0 10 52 86 82 55 97 100 186
2022/20231.072 121 65 48 71 76 244 24 89 148 55 66 65
2023/20241.223 78 32 148 72 37 239 32 55 252 35 37 206
2024/20253.215 46 19 26 524 285 256 235 125 425 307 563 404
2025/20266.899 624 800 492 930 629 508 1.008 310 395 571 380 252
2026/20272.083 232 327 418 1.032 74 0 0 0 0 0 0 0
Totale 19.529